
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZBTB33 (zinc finger and BTB domain containing 33) encodes a transcriptional regulator with bimodal DNA-binding specificity for methylated and non-methylated DNA sequences. The protein contains an N-terminal BTB domain and C-terminal zinc fingers and recruits the N-CoR corepressor complex to promote histone deacetylation and repressive chromatin formation. ZBTB33 can regulate transcription of target genes, including genes associated with Wnt signaling, through interactions with corepressor and catenin proteins.
The 293T cell line is a highly transfectable derivative of the human embryonic kidney (HEK) 293 cell line. Originally designated 293tsA1609neo, it was generated by introducing the SV40 large T-antigen gene and a neomycin resistance gene into an adenovirus-immortalized human embryonic kidney cell subline. The cells express SV40 large T-antigen and support replication of vectors containing the SV40 origin of replication. Due to their high transfection efficiency and favorable properties for gene expression and protein production, 293T cells are widely used for molecular biology studies, recombinant protein expression, and production of viral vectors including retroviral and lentiviral systems.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 3
Reference Transcript: NM_001184742
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use







Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?